Literature DB >> 22978393

Lipids and lysosomes.

Isabelle Hamer1, Guillaume Van Beersel, Thierry Arnould, Michel Jadot.   

Abstract

Lysosomes are cytoplasmic organelles delimited by a single membrane and filled with a variety of hydrolytic enzymes active at acidic pH and collectively capable to degrade the vast majority of macromolecules entering lysosomes via endocytosis, phagocytosis or autophagy. In this review, we describe the lipid composition and the dynamic properties of lysosomal membrane, the main delivery pathways of lipids to lysosomes and their catabolism inside lysosomes. Then, we present the consequences of a lipid accumulation as seen in various lysosomal storage diseases on lysosomal functions. Finally, we discuss about the possible involvement of lysosomes in lipotoxicity.

Entities:  

Mesh:

Year:  2012        PMID: 22978393     DOI: 10.2174/138920012803762684

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  6 in total

1.  Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification.

Authors:  Elena-Raluca Nicoli; Mary R Weston; Mary Hackbarth; Alissa Becerril; Austin Larson; Wadih M Zein; Peter R Baker; John Douglas Burke; Heidi Dorward; Mariska Davids; Yan Huang; David R Adams; Patricia M Zerfas; Dong Chen; Thomas C Markello; Camilo Toro; Tim Wood; Gene Elliott; Mylinh Vu; Wei Zheng; Lisa J Garrett; Cynthia J Tifft; William A Gahl; Debra L Day-Salvatore; Joseph A Mindell; May Christine V Malicdan
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

2.  A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis.

Authors:  Rachel J Church; Hong Wu; Merrie Mosedale; Susan J Sumner; Wimal Pathmasiri; Catherine L Kurtz; Mathew T Pletcher; John S Eaddy; Karamjeet Pandher; Monica Singer; Ameesha Batheja; Paul B Watkins; Karissa Adkins; Alison H Harrill
Journal:  Toxicol Sci       Date:  2014-05-20       Impact factor: 4.849

3.  Lysosomotropic agents selectively target chronic lymphocytic leukemia cells due to altered sphingolipid metabolism.

Authors:  R F Dielschneider; H Eisenstat; S Mi; J M Curtis; W Xiao; J B Johnston; S B Gibson
Journal:  Leukemia       Date:  2015-02-23       Impact factor: 11.528

Review 4.  Lipids, lysosomes, and autophagy.

Authors:  Bharat Jaishy; E Dale Abel
Journal:  J Lipid Res       Date:  2016-06-21       Impact factor: 5.922

5.  Not so transport incompetent after all: Revisiting a CLC-7 mutant sheds new mechanistic light on lysosomal physiology.

Authors:  Alessio Accardi
Journal:  J Gen Physiol       Date:  2021-04-05       Impact factor: 4.086

Review 6.  Deregulation of signalling in genetic conditions affecting the lysosomal metabolism of cholesterol and galactosyl-sphingolipids.

Authors:  S Gowrishankar; S M Cologna; M I Givogri; E R Bongarzone
Journal:  Neurobiol Dis       Date:  2020-10-17       Impact factor: 5.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.